Skip to content

Barry K. Logan

4 papers in the library · 128 citations · publishing 2001-2022

Papers

Sort Most recent Most cited

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review

Journal of Analytical Toxicology April 20, 2022 Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty et al. 66 citations

An important role of modern forensic and clinical toxicologists is to monitor the adverse events of novel psychoactive substances (NPS). Following a prior review from 2013 to 2016, this critical literature review analyzes and evaluates published case reports for NPS from January 2017 through December 2020. The primary objective of this study is to assist in the assessment and interpretation of...

DOI: 10.1093/jat/bkac023 (opens in new tab) Full text (opens in new tab) Synthetic cannabinoids Adverse effect Polypharmacy Hallucinogen +4

Combined dextromethorphan and chlorpheniramine intoxication in impaired drivers.

Journal of Forensic Sciences September 1, 2009 Barry K. Logan

Dextromethorphan is a nonprescription antitussive which has been gaining in popularity as an abused drug, because of the hallucinogenic, dissociative, and intoxicating effects it produces at high doses. This report describes a series of eight drivers arrested for driving under the influence of the combined effects of dextromethorphan and chlorpheniramine, and a further four drivers under the...

Five deaths resulting from abuse of dextromethorphan sold over the internet.

Journal of Analytical Toxicology March 1, 2009 Barry K. Logan, Gary Goldfogel, Rebecca Hamilton et al.

Dextromethorphan is a widely available over-the-counter antitussive that produces intoxicating, hallucinogenic, and dissociative effects at doses significantly exceeding the therapeutic range. We report the deaths of five teenage males in three incidents in three states (WA, FL, and VA) who purposefully ingested large doses of dextromethorphan for recreational purposes and died as a result of...

3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) and Driving Impairment

Journal of Forensic Sciences November 1, 2001 Barry K. Logan, Fiona J. Couper 62 citations

Abstract 3,4-Methylenedioxymethamphetamine, or MDMA, is increasing in popularity in the United States as a drug of abuse. It has stimulant and empathogenic mood altering properties with the potential to affect psychomotor skills and impact driving. This report reviews the literature relating to the relevant psychomotor effects of the drug, the relationship between dose and blood concentrations,...

DOI: 10.1520/jfs15166j (opens in new tab) MDMA Ecstasy Stimulant Psychomotor learning +4